Outcome of early endoscopic biliary drainage in the management of bile leaks after hepatic resection

doi:10.1067/mge.2003.148

Gastrointestinal Endoscopy

Volume 57, Issue 4, April 2003, Pages 526-530

https://doi.org/10.1067/mge.2003.148 Get rights and content

Background: Bile leaks are a major cause of morbidity and mortality after liver resection. Endoscopic stent insertion is the treatment of choice, although the optimal timing of stent placement has not been established. This study reviewed the outcome of early endoscopic biliary stent insertion for treatment of bile leaks after hepatic resection.

Methods: One hundred fifteen patients underwent hepatic resection in a single unit from July 1995 to December 2000. The type of liver resection, clinical presentation of bile leaks, findings on ERCP, and outcomes after stent placement were recorded.

Results: Twenty patients (17%) had bile leaks; 15 had bile in surgical drains but were asymptomatic, and 5 had clinical evidence of a subphrenic collection. In one patient the leak closed spontaneously. The remaining 19 patients underwent ERCP. Fifteen had a leak from a peripheral biliary radical and an endoscopic stent was inserted. Two had a hepatic duct stump leak and were treated by nasobiliary drainage followed by stent insertion. In the remaining 2 patients cholangiography did not demonstrate a leak but a plastic stent was inserted. ERCP was performed a median of 6 days (range 5 to 10 days) after surgery. There was no ERCP-related complication. Median hospital stay in the 95 patients without a bile leak was 10 days (range 4–30 days) compared with 15 days (range 10–41 days) for those with bile leaks (NS). Stents were removed endoscopically at 6 weeks with no persistent leaks detected. There were no late biliary complications (median follow-up 26 months, range 12–72 months).

Conclusions: Early endoscopic biliary stent insertion is effective in the management of bile leakage after hepatic resection.

References (14)

MiyagawaS et al.
Criteria for safe hepatic resection
Am J Surg
(1995)
DociR et al.
Morbidity and mortality after hepatic resection of metastases from colorectal cancer
Br J Surg
(1995)
BrancatisanoR et al.
Is radical hepatic surgery safe?
Am J Surg
(1998)
PaquetJC et al.
Prevention of deep abdominal complications with omentoplasty on the raw surface after hepatic resection
Am J Surg
(2000)
KohnoH et al.
Comparison of topical hemostatic agents in elective hepatic resecton: a clinical prospective randomized trial
World J Surg
(1992)
YamashitaY et al.
Bile leakage after hepatic resection
Ann Surg
(2001)
IjichiM et al.
Randomized trial of the usefulness of a bile leakage test during hepatic resection
Arch Surg
(2000)

There are more references available in the full text version of this article.

Cited by (86)

Over-the-scope-clip treatment for perforation of the duodenum after endoscopic papillectomy
2021, VideoGIE
Liver resection in Cirrhotic liver: Are there any limits?
2020, International Journal of Surgery
Liver resection remains one of the most technically challenging surgical procedure in abdominal surgery due to the complex anatomical arrangement in the liver and its rich blood supply that constitutes about 20% of the cardiac output per cycle. The challenge for resection in cirrhotic livers is even higher because of the impact of surgical stress and trauma imposed on borderline liver function and the impaired ability for liver regeneration in cirrhotic livers. Nonetheless, evolution and advancement in surgical techniques as well as knowledge in perioperative management of liver resection has led to a substantial improvement in surgical outcome in recent decade. The objective of this article was to provide updated information on the recent developments in liver surgery, from preoperative evaluation, to technicality of resection, future liver remnant augmentation and finally, postoperative management of complications.
The impact of bile leakage on long-term prognosis in primary liver cancers after hepatectomy: A propensity-score-matched study
2020, Asian Journal of Surgery
The impact of bile leakage (BL) on the long-term prognosis in patients with primary liver cancers after hepatectomy remains unclear.
One thousand nine hundred and seventy-one consecutive patients with primary liver cancers who underwent curative hepatectomy were enrolled. 75 patients encountered BL, including 34 long-time BL (LTBL) and 41 short-time BL (STBL) according to 4-weeks demarcation. Variables associated with BL were identified using multiple logistic regression analysis. 75 patients without BL were enrolled into the Non-BL group using a one-to-one propensity score matched analysis before assessing the impact of BL on the long-term prognosis. The levels of interleukin-6 (IL-6) and C-reactive protein (CRP) in the serum and drain fluid were detected and compared.
The tumor size, type of liver cancer, operation time, blood loss and blood transfusion were independent risk factors for BL. The long-term survival showed no difference between the patients with and without BL (p > 0.05), while the LTBL was a significant predictor of poor long-term prognosis (p < 0.001). Compared with the patients without BL, the patients with BL had a higher level of IL-6 from postoperative day (POD) 1 to POD 60, and a higher level of CRP from POD 7 to POD 60. By POD 60, the levels of IL-6 and CRP hadn't restored to the normal level in the LTBL group.
The LTBL has a negative impact on the long-term prognosis of patients with primary liver cancers after hepatectomy, in which the inflammatory responses may play a pivotal role.
Endoscopic management of postcholecystectomy biliary leak: When and how? A nationwide study
2019, Gastrointestinal Endoscopy
ERCP is considered the first-line therapy for biliary duct leaks (BDLs). However, the optimal ERCP timing and endotherapy methods remain controversial. Our aim was to evaluate these factors as predictors of poor clinical outcomes after BDLs.
Adults who underwent ERCP for BDLs after cholecystectomy were identified from the Nationwide Inpatient Sample from 2000 to 2014. ERCP was classified as emergent, urgent, and expectant if it was done within 1 day, after 2 to 3 days, or >3 days after BDLs, respectively. Endotherapy was classified into sphincterotomy, stent, or combination. Post-ERCP adverse events (AEs) were defined as requiring pressor infusion, endotracheal intubation, invasive monitoring, or hemodialysis. Early endotherapy failure was defined as the need for salvage surgical or radiology-percutaneous biliary intervention after ERCP.
A total of 1028 patients with a median age of 56 years were included. ERCP was done emergently (19%), urgently (30%), and expectantly (51%). Endotherapy procedures were sphincterotomy (24%), biliary stent (24%), and combination (52%). Post-ERCP AEs were 11%, 10%, and 9% for emergent, urgent, and expectant ERCP, respectively (P = .577). In-hospital mortality showed a U-shape trend of 5%, 0%, and 2% for emergent, urgent, and expectant ERCP, respectively (P < .001). Combination and stent monotherapy had lower failure rates of 3% and 4%, respectively as compared with sphincterotomy monotherapy with failure rate of 11% (P < .001). When multivariate analysis was used, both combination (odds ratio, .2; 95% confidence interval, .1-.5) and stent monotherapy (odds ratio, .4; 95% confidence interval, .2-.9) were less likely to fail as compared with sphincterotomy monotherapy. There were no statistically significant differences between combination therapy and stent monotherapy in the univariate and the multivariate analyses.
Although limited by retrospective design and the possibility of selection bias, this analysis suggests that the timing of ERCP is not a significant predictor of post-ERCP AEs after BDLs. Furthermore, combination or stent monotherapy had lower failure rates as compared with sphincterotomy monotherapy.
Clinical outcomes in patients with bile leaks treated via ERCP with regard to the timing of ERCP: a large multicenter study
2017, Gastrointestinal Endoscopy
Postsurgical or traumatic bile duct leaks (BDLs) can be safely and effectively managed by endoscopic therapy via ERCP. The early diagnosis of BDL is important because unrecognized leaks can lead to serious adverse events (AEs). Our aim was to evaluate the relationship between timing of endotherapy after BDL and the clinical outcomes, AEs, and long-term results of endoscopic therapy.
We conducted a multicenter, retrospective study on patients with BDLs who underwent ERCP between 2006 and 2014. Data were assembled on patient demographics, etiology of BDL, and procedural details. Endotherapy for BDLs were classified a priori into 3 groups based on timing of ERCP from time of biliary injury: within 1 day of BDL, on day 2 or 3 after BDL, and greater than 3 days after BDL. The relationship among timing of ERCP after BDL injury and outcomes, procedure-related AEs, and patient AEs and mortality were evaluated.
From February 2006 to June 2014, 518 patients (50% male; mean age, 51.7 years) underwent ERCP for therapy of BDLs. The etiology of the BDL was laparoscopic cholecystectomy (70.7%), post–liver transplantation (11.2%), liver resection (14.1%), trauma (2.5%), and other causes (1.5%). Endotherapy was performed by placing a transpapillary stent alone (73.5%) or with a sphincterotomy (26.5%). The timing of ERCPs was as follows: ≤1 day = 57 patients, day 2 or 3 = 140 patients, and >3 days = 321 patients. There was no statistical difference in patient demographics, etiology/site of BDL, or type of endotherapy performed among the 3 groups. On multivariate analysis there was no statistically significant difference in BDL success rate for ERCPs performed within 1 day compared with those performed on day 2 or 3 or after 3 days of bile duct injury (91.2%, 90%, and 88.5%, respectively; P = .77). Similarly, there was no significant difference in the overall patient AE rate among the 3 groups (21.1%, 22.9%, and 24.6%, respectively; P = .81). AEs in men occurred significantly more frequently when compared with women, even after adjusting for age, BDL etiology, and location of leak (27.6% vs 19.9%; OR, 1.53; P = .04). Patients whose BDL was due to a cholecystectomy had a lower AE and mortality rate compared with those who had biliary injury from other etiologies (OR, .42; P < .001).
The overall success rates and AEs after ERCP were not dependent on the timing of the procedure relative to the discovery of the bile leak. This suggests that ERCP in these patients can usually be performed in an elective, rather than an urgent, manner.
Benign Biliary Strictures and Leaks
2015, Gastrointestinal Endoscopy Clinics of North America

View all citing articles on Scopus

View full text

Outcome of early endoscopic biliary drainage in the management of bile leaks after hepatic resection

Criteria for safe hepatic resection

Am J Surg

Morbidity and mortality after hepatic resection of metastases from colorectal cancer

Br J Surg

Is radical hepatic surgery safe?

Am J Surg

Prevention of deep abdominal complications with omentoplasty on the raw surface after hepatic resection

Am J Surg

Comparison of topical hemostatic agents in elective hepatic resecton: a clinical prospective randomized trial

World J Surg

Bile leakage after hepatic resection

Ann Surg

Randomized trial of the usefulness of a bile leakage test during hepatic resection

Arch Surg